Lucas Massoth, M.D. (@lucasmassoth) 's Twitter Profile
Lucas Massoth, M.D.

@lucasmassoth

Hematopathologist & Surgical Pathologist | @MGHPathology @harvardmed trained | @UofOklahoma MD | @UArkansas Alum 🐗 | 🇺🇦

ID: 1258911578541391872

calendar_today09-05-2020 00:08:21

644 Tweet

1,1K Followers

609 Following

Lucas Massoth, M.D. (@lucasmassoth) 's Twitter Profile Photo

Burkitt lymphoma, Wright-Giemsa stained bone marrow aspirate. Rare cases may present as pure leukemia with peripheral blood and bone marrow involvement. "The cytoplasm is deeply basophilic and usually contains lipid vacuoles"

Burkitt lymphoma, Wright-Giemsa stained bone marrow aspirate. Rare cases may present as pure leukemia with peripheral blood and bone marrow involvement.

"The cytoplasm is deeply basophilic and usually
contains lipid vacuoles"
Shachar Path (@tiger_heme) 's Twitter Profile Photo

56 yo woman inguinal lymph node - nodular LP B cell Ly. Stains here CD20 and OCT2. But is that all? Open the comments for a surprise 🕵🏻

56 yo woman inguinal lymph node - nodular LP B cell Ly. Stains here CD20 and OCT2. But is that all? Open the comments for a surprise 🕵🏻
Judith Ferry (@judith_ferry) 's Twitter Profile Photo

Pathologists! Check out our review, comparing current and prior WHO Classifications and ICC, focusing on mature B, T, NK cell, plasma cell & histiocytic/ dendritic cell neoplasms. rdcu.be/dM98O #lymphoma #WHO

Judith Ferry (@judith_ferry) 's Twitter Profile Photo

CD45+, CD43+, so could be ALCL, but CD30 was negative. Note the fine chromatin of the neoplastic cells, suggesting blasts. Additional IHC: CD68+, lysosome+, NPM1+. Dx is myeloid sarcoma, NPM1+, c/w NPM1 mutation. #hemepath #heme #myeloid

CD45+, CD43+, so could be ALCL, but CD30 was negative. Note the fine chromatin of the neoplastic cells, suggesting blasts. Additional IHC: CD68+, lysosome+, NPM1+. Dx is myeloid sarcoma, NPM1+, c/w NPM1 mutation. #hemepath #heme #myeloid
Raza Hoda MD (@razahoda) 's Twitter Profile Photo

Triple-Negative Tuesday 🔬 Case of Microglandular Adenosis (MGA) of Breast MGA is a curious lesion of breast that lacks myoepithelial cells but retains basement membrane. MGA is “triple-negative” and can be misdiagnosed as invasive carcinoma. #PathTwitter #PathX #breastpath

Triple-Negative Tuesday 🔬

Case of Microglandular Adenosis (MGA) of Breast

MGA is a curious lesion of breast that lacks myoepithelial cells but retains basement membrane. MGA is “triple-negative” and can be misdiagnosed as invasive carcinoma.

#PathTwitter #PathX #breastpath
Siba El Hussein, MD (@sibaelhussein) 's Twitter Profile Photo

If you diagnose a nodal T-cell lymphoma with these features: -Morphology is blastoid -No monotypic pattern of TRBC1 by flow cytometry analysis -No TCR gene rearrangement by PCR Add a marker of cell immaturity like TDT, CD34, CD117 etc, even if the clinical features are not

If you diagnose a nodal T-cell lymphoma with these features:

-Morphology is blastoid

-No monotypic pattern of TRBC1 by flow cytometry analysis

-No TCR gene rearrangement by PCR

Add a marker of cell immaturity like TDT, CD34, CD117 etc, even if the clinical features are not
Raza Hoda MD (@razahoda) 's Twitter Profile Photo

TRK Thursday 🔬 Case of Secretory Carcinoma of Breast with TRK Immunohistochemistry TRK immunohistochemistry is a sensitive and specific marker for TRK-related neoplasms, such as secretory carcinoma of breast. Can you name other TRK tumors? #PathTwitter #PathX #breastpath

TRK Thursday 🔬

Case of Secretory Carcinoma of Breast with TRK Immunohistochemistry

TRK immunohistochemistry is a sensitive and specific marker for TRK-related neoplasms, such as secretory carcinoma of breast. 

Can you name other TRK tumors?

#PathTwitter #PathX #breastpath
M. Lisa Zhang, MD (@mlisazhang) 's Twitter Profile Photo

🚨 New case report! Despite the ancillary tools we have, there are still gray zone cases straddling the boundary of G3 pancreatic neuroendocrine tumor and neuroendocrine carcinoma. Check out our challenging case: rdcu.be/dTPzN #Pathology #GIPath #PancPath #CaseReport

🚨 New case report! Despite the ancillary tools we have, there are still gray zone cases straddling the boundary of G3 pancreatic neuroendocrine tumor and neuroendocrine carcinoma. 
Check out our challenging case: rdcu.be/dTPzN 

#Pathology #GIPath #PancPath #CaseReport
Judith Ferry (@judith_ferry) 's Twitter Profile Photo

Pathologists! Check out our open access review of Splenic B-cell lymphomas at this link: doi.org/10.1111/his.15… #spleen #lymphoma

Judith Ferry (@judith_ferry) 's Twitter Profile Photo

Pathologists! What is your differential diagnosis for this symptomatic lesion of the spinal cord in a middle-aged female? What immunostains or special studies might help you? Hint: CNS involvement is common, although spinal cord is an unusual site. #HemePath

Pathologists! What is your differential diagnosis for this symptomatic lesion of the spinal cord in a middle-aged female? What immunostains or special studies might help you? Hint: CNS involvement is common, although spinal cord is an unusual site. #HemePath
Judith Ferry (@judith_ferry) 's Twitter Profile Photo

Pathologists! Here is a classic case of Burkitt lymphoma, EBV+, presenting as a nasopharyngeal mass in a little boy. Fortunately, therapy is good and the prognosis is favorable. #Hemepath #Lymphoma

Pathologists! Here is a classic case of Burkitt lymphoma, EBV+, presenting as a nasopharyngeal mass in a little boy. Fortunately, therapy is good and the prognosis is favorable. #Hemepath #Lymphoma
Judith Ferry (@judith_ferry) 's Twitter Profile Photo

Pathologists! What do you think of this lymph node from 33 yo male with multifocal lymphadenopathy? What other work up would you do? #hemepath #lymphnodes

Pathologists! What do you think of this lymph node from 33 yo male with multifocal lymphadenopathy? What other work up would you do?
#hemepath #lymphnodes
Vikram Deshpande (@vik_deshpandemd) 's Twitter Profile Photo

I’m genuinely glad the Hempath, WHO, and ICC groups are getting along now. Kissing and making up is great. But here’s a cold, hard truth: I’d bet that in your 7th classification, the vast majority of what you include will be inaccessible to 80% of the world’s population. Let